Cleveland BioLabs
CBLI
#10382
Rank
NZ$86.88 M
Marketcap
NZ$5.61
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Earnings for Cleveland BioLabs (CBLI)

Earnings in 2021 (TTM): -NZ$3.97 Million

According to Cleveland BioLabs 's latest financial reports the company's current earnings are NZ$0.63 Million. In 2020 the company made an earning of -NZ$4.55 Million a decrease over its 2019 earnings that were of -NZ$4.19 Million.

Earnings history for Cleveland BioLabs from 2004 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$3.97 Million-12.87%
2020-NZ$4.55 Million8.8%
2019-NZ$4.19 Million-50.81%
2018-NZ$8.5 Million-14.3%
2017-NZ$9.92 Million-11.88%
2016-NZ$11.26 Million-50.9%
2015-NZ$22.93 Million-10.24%
2014-NZ$25.54 Million-37.5%
2013-NZ$40.87 Million-23.2%
2012-NZ$53.21 Million19.68%
2011-NZ$44.46 Million133.81%
2010-NZ$19.02 Million68.22%
2009-NZ$11.31 Million-55.51%
2008-NZ$25.41 Million-45.62%
2007-NZ$46.72 Million255.63%
2006-NZ$13.14 Million198.18%
2005-NZ$4.41 Million-1.25%
2004-NZ$4.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$27.48 B-564,011.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$59.48 B-1,220,621.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$18.21 B-373,824.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$12.67 B-260,232.02%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$21.08 B-432,788.12%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$13.96 B-286,724.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-NZ$20.73 Million 325.20%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-NZ$0.15 Billion 2,800.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$32.15 Million 559.60%๐Ÿ‡บ๐Ÿ‡ธ USA